David J. Cohen
Drug-eluting coronary stents (DES) have reduced rates of restenosis and repeat revascularization compared with bare-metal stents (BMS), but
C. Richard Conti
&NA;
Howard C. Herrmann
Ali AboufaresStephen R. Ramee